Church & Dwight Co., Inc. (CHD)

Q2 2026 Earnings Preview

Ticker

CHD

Earnings Date

July 31, 2026

Reporting Period

Q2 2026 (ending June 30, 2026)

Prepared

July 30, 2026

Last Earnings

May 1, 2026 (Q1 2026)

Sector ETF

XLP (Consumer Staples Select Sector SPDR)

1. Earnings Preview

Key Takeaway: The setup is mixed — CHD beat handily in Q1 but guided Q2 adjusted EPS to $0.88, well below the then-consensus of ~$0.93, making the bar achievable; the single biggest swing factor is whether transportation/commodity cost mitigation is tracking ahead of schedule, which could allow a modest EPS beat even against a reset bar.

Heading into the Q2 2026 print, the bar has been deliberately reset lower: management guided Q2 adjusted EPS to $0.88 on the May 1 call, a figure that sat materially below the pre-print Street consensus and has since been largely adopted by analysts, leaving consensus at ~$0.89. Organic sales growth of ~3% is the guided target for the quarter, with gross margin expansion of only ~50 bps — a step-down from Q1's stronger delivery — as Middle East-driven transportation and commodity cost pressures are expected to peak in Q2 before productivity offsets kick in during H2. Management's tone at the June 2 Deutsche Bank conference was explicitly optimistic, reiterating all full-year targets (3–4% organic growth, 5–8% EPS growth, $1.15B cash flow) with CFO McChesney noting "far more tailwinds" than headwinds from the May 1 vantage point, suggesting no deterioration in the underlying business. Estimate revisions have been stable-to-slightly-down since the Q1 print — the Q2 EPS consensus moved from ~$0.93 pre-print to ~$0.89 post-print and has barely budged since, implying the Street has fully digested the guidance reset without further cuts, which is a mild positive. The stock has traded essentially flat since the Q1 print (up ~2% vs. XLP up ~1.5%), suggesting the market has neither priced in a beat nor a miss, leaving the stock setup neutral. The key wildcard is Touchland consumption trajectory — management maintained double-digit full-year growth expectations despite a tracked-channel slowdown in Q1, and any Q2 data point (positive or negative) on Touchland's untracked-channel performance could move sentiment disproportionately given the brand's premium valuation contribution.

2. KPIs & Consensus Expectations

Key Takeaway: Consensus reflects management's own Q2 guidance almost exactly, making the bar achievable but not low; organic sales growth (~3%) is the bigger swing factor given Q1's 5% beat, while EPS ($0.88–$0.89) is tightly anchored to guidance and leaves little room for surprise in either direction.

Table 1 — Current Quarter Snapshot (Q2 2026 Key KPIs)

KPI

Last Quarter Actual (Q1 2026)

Prior Year Period (Q2 2025 Actual)

Q2 2026 Consensus Estimate

YoY Change

Q2 2026 Guidance (Mgmt)

Consensus vs. Guidance

Net Sales ($M)

$1,469.3M

$1,506.3M

$1,502.9M

-0.2% YoY

~-1% reported (organic ~+3%)

~+0.2% above guidance midpoint

Organic Sales Growth (%)

+5.0%

+0.1%

~+3.3%

+3.2 pp YoY

~+3%

~+30 bps above guidance

Adj. EPS - Diluted - Operating ($)

$0.95

$0.94

$0.89

-5.3% YoY

$0.88

+$0.01 / +1.1% above guidance

Gross Profit - Operating ($M)

$681.4M

$677.4M

$683.7M

+0.9% YoY

~+50 bps expansion

Broadly in line with guidance

Sources: Visible Alpha Consensus and Actuals Data (Net Sales, Organic Growth, Adj. EPS, Gross Profit). Q2 2026 guidance from CHD Q1 2026 Earnings Call (May 1, 2026) and Deutsche Bank Global Consumer Conference (June 2, 2026).

Table 2 — Beat/Miss History (Last 8 Quarters, Top 2 KPIs)

KPI 1: Organic Sales Growth (%)

Quarter

Reported

Consensus

Surprise (pp)

Result

Q2 2024

+4.3%

+3.3%

+1.0 pp

Beat

Q3 2024

+4.3%

+3.3%

+1.0 pp

Beat

Q4 2024

+4.2%

+3.0%

+1.2 pp

Beat

Q1 2025

-1.2%

+1.5%

-2.7 pp

Miss

Q2 2025

+0.1%

-0.7%

+0.8 pp

Beat

Q3 2025

+3.4%

+1.5%

+1.9 pp

Beat

Q4 2025

+0.7%

+1.7%

-1.0 pp

Miss

Q1 2026

+5.0%

+3.4%

+1.6 pp

Beat

KPI 2: Adjusted EPS - Diluted - Operating ($)

Quarter

Reported

Consensus

Surprise (%)

Result

Q2 2024

$0.94

$0.85

+10.6%

Beat

Q3 2024

$0.79

$0.68

+16.2%

Beat

Q4 2024

$0.77

$0.77

0.0%

In Line

Q1 2025

$0.91

$0.90

+1.1%

Beat

Q2 2025

$0.94

$0.85

+10.6%

Beat

Q3 2025

$0.81

$0.74

+9.5%

Beat

Q4 2025

$0.86

$0.83

+3.6%

Beat

Q1 2026

$0.95

$0.93

+2.2%

Beat

Pattern: CHD has beaten adjusted EPS consensus in 7 of the last 8 quarters, with the sole exception being Q4 2024 (in-line). Organic sales beats are also the norm (6 of 8), with the two misses concentrated in Q1 2025 (VMS divestiture drag) and Q4 2025 (portfolio transition). The consistent EPS beat pattern reflects CHD's tendency to guide conservatively, though the Q2 2026 guidance was unusually specific ($0.88) and well-telegraphed, which may limit upside surprise.

Source: Visible Alpha Consensus and Actuals Data.

3. Guidance & Commentary Evolution

Key Takeaway: Full-year 2026 guidance has been fully reiterated since the May 1 Q1 print with no changes; tone has shifted modestly more optimistic at the June 2 Deutsche Bank conference, with CFO McChesney citing "far more tailwinds" and expressing confidence in the H2 productivity ramp.

Metric

Initial Guidance (May 1, 2026 Q1 Call)

Revised Guidance

Current Consensus

Note

FY2026 Organic Sales Growth

~3% to 4%

~3.8%

Reiterated at DB Conference June 2; unchanged

FY2026 Reported Sales Growth

-1.5% to -0.5%

~-0.5%

Unchanged; reflects VMS/portfolio exit drag

FY2026 Adj. EPS Growth

+5% to +8%

~+6.5% (implies ~$3.75)

Reiterated at DB Conference June 2; unchanged

FY2026 Gross Margin Expansion

~+100 bps vs. 2025

In line with guidance

Unchanged; productivity offsets Middle East inflation

FY2026 Marketing (% of Sales)

~11%

~11%

Unchanged; in line with evergreen model

FY2026 Free Cash Flow

~$1.15B

~$1.15B

Reiterated at DB Conference June 2; unchanged

FY2026 CapEx (% of Sales)

~2% of sales

~2% of sales

Unchanged

Q2 2026 Adj. EPS

$0.88

~$0.89

Consensus has converged to guidance; no post-call revision

Q2 2026 Organic Sales Growth

~+3%

~+3.3%

Consensus slightly above guidance midpoint

Q2 2026 Gross Margin Expansion

~+50 bps

In line with guidance

Transportation cost pressure peaks in Q2; mitigation in H2

Sources: CHD Q1 2026 Earnings Call transcript (May 1, 2026); CHD Deutsche Bank Global Consumer Conference transcript (June 2, 2026); Visible Alpha Consensus Data.

4. Guidance vs. Estimate Revision Tracker

Key Takeaway: Q2 EPS estimates dropped sharply post-Q1 print (from ~$0.93 to ~$0.89) as the Street absorbed the below-consensus Q2 guidance, but have been stable since; full-year estimates have barely moved, suggesting analysts believe the H2 productivity ramp is credible and the full-year guidance range is intact.

KPI (Period)

Estimate ~5 Days Post Q1 Print (as of ~May 8, 2026)

Current Consensus (July 30, 2026)

Estimate Δ (%)

Initial Guidance (May 1 Call)

Current Guidance

Guidance Δ

Consensus vs. Guidance (%)

Adj. EPS (Q2 2026)

$0.894

$0.894

0.0%

$0.88

$0.88 (unchanged)

+1.6% above guidance

Organic Sales Growth (Q2 2026)

~+3.2%

~+3.3%

+0.1 pp

~+3%

~+3% (unchanged)

+30 bps above guidance

Net Sales (Q2 2026)

$1,497.4M

$1,502.9M

+0.4%

~-1% reported

~-1% reported (unchanged)

Broadly in line

Adj. EPS (FY2026)

$3.749

$3.753

+0.1%

+5% to +8% growth

+5% to +8% (unchanged)

~+6.5% growth; mid-range of guidance

Organic Sales Growth (FY2026)

~+3.8%

~+3.8%

0.0%

~3% to 4%

~3% to 4% (unchanged)

Near top of guidance range

Net Sales (FY2026)

$6,147.1M

$6,177.9M

+0.5%

-1.5% to -0.5% reported

-1.5% to -0.5% (unchanged)

Near top of guidance range

The key takeaway from the revision tracker is that the Street has fully absorbed the Q2 guidance reset and has not made further cuts — a sign of confidence in the H2 productivity ramp. Full-year estimates are essentially unchanged since the Q1 print, implying analysts believe the $25–30M Middle East cost headwind is manageable and that the back-half acceleration in gross margin is credible.

Source: Visible Alpha Consensus and Actuals Data (as-of date: May 8, 2026 for baseline; current as of July 30, 2026). Guidance from CHD Q1 2026 Earnings Call (May 1, 2026).

5. Stock Performance

Key Takeaway: CHD has essentially tracked XLP since the Q1 print, with modest multiple expansion (+1–2%) driving the slight outperformance rather than estimate revisions (which were flat); the stock has not priced in a beat or a miss, leaving the setup balanced.

Since the Q1 2026 earnings date (May 1, 2026), CHD closed at $96.02 on that day and traded to $97.68 by July 31, 2026 — a gain of approximately +1.7% on an absolute basis. Over the same period, XLP (Consumer Staples Select Sector SPDR ETF) gained approximately +1.5% and the S&P 500 (SPY) gained approximately +2.9%. CHD thus slightly outperformed XLP but lagged the broader market. The stock's NTM P/E has expanded modestly from ~25.2x to ~25.5x over the past three months, consistent with the broader consumer staples re-rating. The performance decomposition confirms that multiple expansion, not estimate revisions, drove the modest outperformance — a pattern that is typical for CHD in periods of stable guidance. No material single-day moves occurred post-Q1 print, with the stock's intraday range on May 1 (from ~$96 to a pre-market high before settling) being the largest event. The stock's relative flatness vs. XLP suggests the market is treating CHD as a sector-neutral hold heading into Q2 results.

Chart: CHD vs. XLP vs. S&P 500 — Indexed Since May 1, 2026 (Last Earnings Date)

Date

CHD (Indexed)

XLP (Indexed)

SPY (Indexed)

May 1, 2026 (Base = 100)

100.0

100.0

100.0

May 8, 2026

97.3

100.0

102.4

May 22, 2026

100.2

100.7

103.5

June 2, 2026 (DB Conference)

100.1

97.2

105.4

June 16, 2026

102.5

101.7

104.1

June 30, 2026

100.9

98.7

103.6

July 16, 2026

103.2

101.9

104.2

July 29, 2026

104.0

103.8

101.2

July 31, 2026 (Latest)

101.7

101.5

102.9

Note: Indexed to 100 at May 1, 2026 close. CHD = $96.02, XLP = $84.17, SPY = $720.65. Key event marked: June 2, 2026 — Deutsche Bank Global Consumer Conference (guidance reiterated, optimistic tone). Sector ETF: XLP (Consumer Staples Select Sector SPDR) — appropriate for CHD's household and personal care sub-sector.

Source: Stock Price Data (Yahoo Finance).

6. Material News & Developments

Key Takeaway: The most important post-Q1 development is the Miss Mouth's Messy Eater acquisition close (late May 2026), which adds a fast-growing digitally-native stain fighter brand with low household penetration and significant distribution runway; the deal is EPS-neutral in 2026 and accretive to cash earnings in 2027, so it is not a near-term EPS swing factor but validates CHD's M&A pipeline and brand-building strategy.

7. Insider Transaction Activity

Key Takeaway: All five insider transactions since the Q1 print are open-market sales — no open-market buys — but the sales are clustered in June and appear to be discretionary (no 10b5-1 plan flags in the data); the volume is modest relative to holdings and does not constitute a strong negative signal, though the absence of any buying is worth noting.

Name

Title

Transaction Type

Shares

Date

Note

Linares, Carlos G.

EVP, Chief Technology & Global New Products

Open Market Sale

10,000

June 16, 2026

Discretionary; no 10b5-1 plan. Leaves 4,668 shares post-sale.

Shearer, Robert K.

Director

Open Market Sale

8,600

June 11, 2026

Discretionary; no 10b5-1 plan. Retains 39,278 shares.

Buchert, Brian D.

EVP of Strategy, M&A, and Business Planning

Open Market Sale

10,160

June 10, 2026

Discretionary; no 10b5-1 plan. Leaves only 1,286 shares post-sale — notable reduction.

Saligram, Ravichandra K.

Director

Open Market Sale (Indirect)

12,960

June 10, 2026

Held via revocable trust; no 10b5-1 plan. Retains 13,653 shares.

Price, Penry W.

Director

Open Market Sale

5,960

May 13, 2026

Discretionary; no 10b5-1 plan. Retains 30,070 shares.

The cluster of five sales across two directors and three executives in May–June 2026 is notable in its breadth, though the individual amounts are modest relative to retained holdings for most sellers. The most notable transaction is Buchert (EVP Strategy & M&A) reducing his direct holding to just 1,286 shares — a near-full liquidation of his direct position. No open-market buys were recorded in the period. No 10b5-1 plan flags were present in the data, suggesting these are discretionary sales, though the timing (post-Q1 beat, stock near $95–$98) is consistent with opportunistic profit-taking rather than a negative fundamental signal.

Source: SEC Form 4 Filings (Insider Transaction Data).

8. Peer Commentary — Current-Quarter (Q2 2026) Read-Through

Key Takeaway: Peer commentary from May–June 2026 consistently points to a stressed but resilient consumer, flat-to-low-single-digit category growth, and meaningful Middle East-driven commodity/transportation cost pressure — all consistent with CHD's own Q2 guidance. The read-throughs are directionally supportive of CHD's organic growth target (~3%) but reinforce that gross margin expansion will be limited in Q2, with recovery dependent on H2 productivity execution.

Note on scope: Only commentary from the last 60 days (on or after May 30, 2026) that explicitly addresses calendar Q2 2026 / June-quarter conditions or forward outlook is included below. Retrospective Q1 2026 results commentary from peers is excluded. Each read-through includes explicit limitations.

8.1 Clorox (CLX) — Deutsche Bank Global Consumer Conference, June 3, 2026

Relevance: CLX is CHD's closest household cleaning peer, with overlapping categories (laundry, cleaning, litter). CLX's CFO provided explicit Q2 2026 (CLX's fiscal Q4) cost and margin commentary.

CHD Read-Through: CLX's ~150 bps gross margin headwind from Middle East costs in calendar Q2 is directionally consistent with CHD's own guidance of only ~50 bps gross margin expansion in Q2 (vs. ~100 bps for the full year), implying the cost pressure is real and front-loaded. The "flat to 1%" category growth observation is more bearish than CHD's own Q2 organic growth guidance of ~3%, but CHD's portfolio skews more toward personal care and premium brands with higher category growth rates. The value-seeking consumer dynamic benefits CHD's ARM & HAMMER franchise.

Limitations: CLX's fiscal Q4 ends in June, so the timing aligns with CHD's Q2, but CLX's category mix (heavy in cleaning/disinfecting) differs from CHD's more diversified personal care/household portfolio. CLX's specific gross margin figures are not directly comparable to CHD's cost structure or hedging position.

8.2 Procter & Gamble (PG) — Deutsche Bank Global Consumer Conference, June 3, 2026

Relevance: PG is the largest household and personal care peer, with broad category overlap. PG's fiscal Q4 (ending June 2026) commentary is directly relevant to CHD's Q2 2026 conditions.

CHD Read-Through: PG's confirmation that "almost all" of its $150M Middle East cost headwind hits in calendar Q2 2026 is a strong read-through for CHD's own Q2 gross margin pressure. The surfactant supply disruption (20% of global feedstock lost) is directly relevant to CHD's cleaning and laundry products. PG's international strength (4% category growth) is a positive read-through for CHD's International segment, which management guided to ~7% organic growth for the full year. The U.S. consumer stability at 2–3% over rolling 12-week periods is broadly consistent with CHD's ~3% Q2 organic growth guidance.

Limitations: PG's scale ($80B+ revenue) means its commodity cost figures are not directly translatable to CHD's ~$6B revenue base. PG's Baby Care competitive dynamics (heavy price competition) may not apply to CHD's baby care exposure (WaterWipes). PG's fiscal year ends June 30, so its Q4 commentary is directly calendar-aligned with CHD's Q2.

8.3 Kimberly-Clark (KMB) — Deutsche Bank Global Consumer Conference, June 4, 2026

Relevance: KMB is a household and personal care peer with overlapping consumer demographics and distribution channels. KMB's commentary on Q2 2026 conditions and cost dynamics is relevant to CHD's household segment.

CHD Read-Through: KMB's observation that shipments may lag consumption by ~200 bps in Q2 is a useful caution for interpreting CHD's reported net sales vs. organic growth. The resilient North American consumer for daily-use staples is broadly supportive of CHD's household and personal care volumes. KMB's strong international performance (Brazil, Indonesia, Vietnam) is a positive read-through for CHD's International segment. KMB's disciplined promotional posture suggests the competitive environment in household/personal care is not aggressively promotional, which is favorable for CHD's margins.

Limitations: KMB's categories (diapers, bath tissue, feminine care) are less price-elastic than some of CHD's personal care categories. KMB's specific productivity program metrics are not directly comparable to CHD's cost structure. The international markets cited (Brazil, Indonesia, Vietnam) may not overlap with CHD's primary international markets.

8.4 e.l.f. Beauty (ELF) — Deutsche Bank Global Consumer Conference, June 4, 2026

Relevance: ELF is a digitally-native personal care/beauty brand with overlapping consumer demographics to CHD's premium personal care brands (TheraBreath, Touchland, Hero). ELF's commentary on consumer sentiment and price elasticity in Q2 2026 is relevant to CHD's premium brand portfolio.

CHD Read-Through: ELF's observation of "higher unit decline" and high price elasticity in the personal care/beauty space is a mild negative read-through for CHD's premium personal care brands (TheraBreath, Touchland, Hero), which are also in the early household penetration phase and dependent on consumer willingness to try premium products. The "challenging consumer segment" commentary reinforces CHD's own cautious tone on the consumer. However, CHD's value brands (ARM & HAMMER) are insulated from this dynamic and may benefit from trade-down. The U.K. promotional environment is worth monitoring for CHD's international segment.

Limitations: ELF operates primarily in cosmetics/skincare, which has different demand elasticity and consumer drivers than CHD's household cleaning and oral care categories. ELF's tariff refund is a unique situation with no direct CHD analog. The price elasticity data points are specific to ELF's price points and product categories.

8.5 Colgate-Palmolive (CL) — Deutsche Bank Global Consumer Conference, June 3, 2026

Relevance: CL is a direct peer in oral care (overlapping with CHD's TheraBreath and ARM & HAMMER oral care) and household products. CL's commentary on North American demand deceleration in early Q2 2026 is the most timely and specific read-through available.

CHD Read-Through: CL's observation of North American category deceleration in early May 2026 is the most directly relevant and timely read-through for CHD's Q2 organic growth. If the "markedly slow" trend in the first weeks of May persisted through June, CHD's ~3% Q2 organic growth guidance could be at risk — though CHD's portfolio mix (more personal care, less oral care) and its ARM & HAMMER value positioning may provide some insulation. CL's Latin America resilience is a positive read-through for CHD's International segment. CL's shift from gross margin expansion to contraction guidance is a cautionary signal for CHD's own ~50 bps Q2 gross margin expansion target.

Limitations: CL's North America deceleration observation was based on only 3 weeks of data from early May and management explicitly noted it was "too early to tell" if the trend would persist. CL's oral care category dynamics may not fully translate to CHD's oral care brands (TheraBreath is a premium therapeutic brand with different demand drivers than commodity toothpaste). CL's gross margin guidance shift reflects its own cost structure and hedging position, which differs from CHD's.

8.6 Peer Read-Through Summary Table

Peer

Event Date

Key Q2 2026 Signal

Direction for CHD

Confidence

CLX

June 3, 2026

U.S. categories flat to +1%; Middle East costs = ~150 bps GM headwind in Q2

Neutral/Negative on GM; Neutral on organic growth (CHD's categories grow faster)

High (direct calendar overlap)

PG

June 3, 2026

U.S. consumer stable at 2–3%; intl. categories +4%; Middle East costs peak in fiscal Q4 (= cal. Q2)

Positive on organic growth; Negative on GM (cost peak in Q2)

High (fiscal Q4 = cal. Q2)

KMB

June 4, 2026

Consumer resilient for daily-use staples; shipments may lag consumption ~200 bps; intl. very strong

Positive on volumes; caution on reported sales vs. organic gap

Medium (category mix differs)

ELF

June 4, 2026

Challenging consumer segment; higher unit decline; high price elasticity; U.K. more promotional

Mild negative for CHD's premium personal care brands (Touchland, Hero, TheraBreath)

Low-Medium (beauty vs. household)

CL

June 3, 2026

N. America categories "markedly slow" in early May; LatAm healthy; GM guidance shifted to down

Negative on N. America organic growth risk; Negative on GM; Positive on intl.

Medium (3 weeks of data only; oral care overlap)

Sources: CLX Deutsche Bank Global Consumer Conference transcript (June 3, 2026); PG Deutsche Bank Global Consumer Conference transcript (June 3, 2026); KMB Deutsche Bank Global Consumer Conference transcript (June 4, 2026); ELF Deutsche Bank Global Consumer Conference transcript (June 4, 2026); CL Deutsche Bank Global Consumer Conference transcript (June 3, 2026).